Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreak

Authors:

Abstract
Background and aims: inflammatory bowel disease (IBD) affects many aspects of a patient's life and impairs their health-related quality of life (HRQoL). The COVID-19 out-break has led to important mobility restrictions and a dra-matic re-adjustment of social habits and health systems. This study aimed to assess the influence of the outbreak and mo-bility restrictions on the HRQoL of IBD patients with stable clinical remission on biologic treatment. Their self-perceived stress scores during the outbreak were also assessed. Methods: a prospective, observational study was performed in IBD patients on biologic treatment with stable clinical re-mission. Patients with both Crohn's disease (CD) and ulcerati-ve colitis (UC)were included. Patients filled in the IBDQ9 and the Perceived Stress Scale (PSS) electronically. To determine any changes, the results of the IBDQ9 during the outbreak were compared with the last IBDQ9 before the outbreak. Results: one hundred and six patients in clinical remission were included, with a median age of 42 years; 42 % were female and 77 % had CD. Median pre-COVID-19 IBDQ9 was 72.1 (66.5-80.12) and decreased to 69.2 (63.1-77.10) during the outbreak (p < 0.001). The median PSS score was 12 (9-19). There was a significant negative correlation between the PSS and the outbreak IBDQ9 (r =-0.66, p < 0.001). Re-gression analysis showed that the PSS score was associated with a lower IBDQ9 during the outbreak (p < 0.001). Conclusion: there was a negative impact of the COVID-19 outbreak on the HRQoL of IBD patients in remission, with higher self-perceived stress scores associated with a lower QoL. The COVID-19 outbreak may have long-term implica- tions for the HRQoL in these patients.

This publication has 18 references indexed in Scilit: